Nita Ahuja
#18,609
Most Influential Person Now
Surgeon
Nita Ahuja's AcademicInfluence.com Rankings
Nita Ahujamedical Degrees
Medical
#678
World Rank
#902
Historical Rank
Surgery
#78
World Rank
#115
Historical Rank
Oncology
#142
World Rank
#147
Historical Rank
Nita Ahujaphilosophy Degrees
Philosophy
#8233
World Rank
#11574
Historical Rank
Logic
#6966
World Rank
#8545
Historical Rank
Download Badge
Medical Philosophy
Nita Ahuja's Degrees
- Bachelors Biology Stanford University
Similar Degrees You Can Earn
Why Is Nita Ahuja Influential?
(Suggest an Edit or Addition)According to Wikipedia, Nita Ahuja is a surgeon and the Chair of the Department of Surgery at Yale School of Medicine and Surgeon-in-Chief of Surgery at Yale New Haven Hospital. She is the first woman ever to serve as Chair of Surgery in Yale in its >200 year history. Before taking this position she was the first woman ever to be the Chief of Surgical Oncology at Johns Hopkins Hospital, Baltimore, USA. Ahuja researches in the field of epigenetics and is a passionate advocate of clinician scientist. She also served as the director of Sarcoma and peritoneal surface malignancy program. She is a surgeon-scientist and her research has been cited more than 11,000 times in scientific literature.
Nita Ahuja's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- CpG island methylator phenotype in colorectal cancer. (1999) (2332)
- Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. (1998) (2005)
- Accelerated age-related CpG island methylation in ulcerative colitis. (2001) (655)
- Aging and DNA methylation in colorectal mucosa and cancer. (1998) (649)
- Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. (1999) (558)
- Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells. (2012) (548)
- Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. (1999) (508)
- Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. (2000) (476)
- Is There a Difference in Survival Between Right- Versus Left-Sided Colon Cancers? (2008) (437)
- Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers (2017) (387)
- Comparing the DNA Hypermethylome with Gene Mutations in Human Colorectal Cancer (2007) (358)
- Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma (2016) (354)
- Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers (2014) (344)
- A combination of molecular markers and clinical features improve the classification of pancreatic cysts. (2015) (339)
- Association between CpG island methylation and microsatellite instability in colorectal cancer. (1997) (324)
- Epigenetic Therapeutics: A New Weapon in the War Against Cancer. (2016) (264)
- Breast Cancer Methylomes Establish an Epigenomic Foundation for Metastasis (2011) (260)
- DNA methylation and environmental exposures in human hepatocellular carcinoma. (2002) (257)
- A Systematic Review of Solid-Pseudopapillary Neoplasms: Are These Rare Lesions? (2014) (252)
- A DNA hypermethylation module for the stem/progenitor cell signature of cancer (2011) (235)
- 2564 resected periampullary adenocarcinomas at a single institution: trends over three decades. (2014) (234)
- Surgical management of solid-pseudopapillary neoplasms of the pancreas (Franz or Hamoudi tumors): a large single-institutional series. (2009) (234)
- Combining Epigenetic and Immunotherapy to Combat Cancer. (2016) (226)
- Aging, methylation and cancer. (2000) (216)
- Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. (2009) (212)
- Histopathologic Basis for the Favorable Survival after Resection of Intraductal Papillary Mucinous Neoplasm-Associated Invasive Adenocarcinoma of the Pancreas (2010) (208)
- Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancer. (2008) (177)
- Methylation and silencing of the Thrombospondin-1 promoter in human cancer (1999) (169)
- Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases (2013) (161)
- Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors. (2008) (161)
- Assessing Readmission After General, Vascular, and Thoracic Surgery Using ACS-NSQIP (2013) (160)
- The CpG island methylator phenotype: what's in a name? (2013) (152)
- The Impact of Postoperative Complications on the Administration of Adjuvant Therapy Following Pancreaticoduodenectomy for Adenocarcinoma (2014) (151)
- Convergence of Mutation and Epigenetic Alterations Identifies Common Genes in Cancer That Predict for Poor Prognosis (2008) (150)
- Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis. (2014) (143)
- Genomic and Epigenomic Integration Identifies a Prognostic Signature in Colon Cancer (2011) (143)
- Pancreatic Resection of Isolated Metastases from Nonpancreatic Primary Cancers (2008) (143)
- Predictors of Survival After Resection of Retroperitoneal Sarcoma: A Population-Based Analysis and Critical Appraisal of the AJCC Staging System (2009) (142)
- Is it necessary to follow patients after resection of a benign pancreatic intraductal papillary mucinous neoplasm? (2013) (136)
- Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma (2016) (127)
- Harnessing the potential of epigenetic therapy to target solid tumors. (2014) (126)
- The CpG island methylator phenotype in colorectal cancer: progress and problems. (2012) (125)
- Novel Methylation Biomarker Panel for the Early Detection of Pancreatic Cancer (2013) (120)
- Is minimally invasive colon resection better than traditional approaches?: First comprehensive national examination with propensity score matching. (2014) (117)
- The Future of Basic Science in Academic Surgery: Identifying Barriers to Success for Surgeon-scientists (2017) (116)
- Ensuring Equity, Diversity, and Inclusion in Academic Surgery: An American Surgical Association White Paper (2018) (111)
- Management and Recurrence Patterns of Desmoids Tumors: A Multi-institutional Analysis of 211 Patients (2012) (110)
- Erratum to: Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group (2016) (104)
- Duodenal Adenocarcinoma: Clinicopathologic Analysis and Implications for Treatment (2012) (101)
- Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study (2016) (99)
- Neutrophil-to-lymphocyte Ratio is a Predictive Marker for Invasive Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas (2017) (92)
- Epigenetic Regulation of WNT Signaling Pathway Genes in Inflammatory Bowel Disease (IBD) Associated Neoplasia (2008) (91)
- Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood (2019) (85)
- Aging-like Spontaneous Epigenetic Silencing Facilitates Wnt Activation, Stemness, and BrafV600E-Induced Tumorigenesis. (2019) (84)
- Concordant methylation of the ER and N33 genes in glioblastoma multiforme (1998) (81)
- Predicting the risk of perioperative mortality in patients undergoing pancreaticoduodenectomy: a novel scoring system. (2011) (81)
- What constitutes a "high-volume" hospital for pancreatic resection? (2008) (80)
- Prognostic significance of Gremlin1 (GREM1) promoter CpG island hypermethylation in clear cell renal cell carcinoma. (2010) (73)
- Epigenetic therapy in gastrointestinal cancer: the right combination (2016) (72)
- DNA Methylation Patterns Separate Senescence from Transformation Potential and Indicate Cancer Risk. (2018) (71)
- Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma. (2016) (69)
- Inhibiting DNA methylation activates cancer testis antigens and expression of the antigen processing and presentation machinery in colon and ovarian cancer cells (2017) (67)
- Hospital Volume and Patient Outcomes in Hepato-Pancreatico-Biliary Surgery: Is Assessing Differences in Mortality Enough? (2014) (66)
- A comparison of open and minimally invasive surgery for hepatic and pancreatic resections using the Nationwide Inpatient Sample. (2014) (66)
- Early-stage gallbladder cancer in the Surveillance, Epidemiology, and End Results database: effect of extended surgical resection. (2011) (66)
- A Roadmap for Aspiring Surgeon-Scientists in Today's Healthcare Environment (2019) (65)
- The Role of Ultrasound-Guided Fine-Needle Aspiration of Axillary Nodes in the Staging of Breast Cancer (2008) (65)
- Multilevel analysis of the impact of community vs patient factors on access to immediate breast reconstruction following mastectomy in Maryland. (2008) (64)
- Combination epigenetic therapy in metastatic colorectal cancer (mCRC) with subcutaneous 5-azacitidine and entinostat: a phase 2 consortium/stand Up 2 cancer study (2017) (61)
- DNA methylation biomarker candidates for early detection of colon cancer (2012) (61)
- Functional Identification of Cancer-Specific Methylation of CDO1, HOXA9, and TAC1 for the Diagnosis of Lung Cancer (2014) (61)
- Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG (2019) (60)
- Biomarkers for detection and prognosis of breast cancer identified by a functional hypermethylome screen (2012) (60)
- Frequent Inactivation of Cysteine Dioxygenase Type 1 Contributes to Survival of Breast Cancer Cells and Resistance to Anthracyclines (2013) (59)
- Understanding the Barriers to Hiring and Promoting Women in Surgical Subspecialties. (2016) (56)
- Management of metastatic retroperitoneal sarcoma: a consensus approach from the Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG)† (2018) (55)
- Extrathoracic Location and “Borderline” Histology are Associated with Recurrence of Solitary Fibrous Tumors After Surgical Resection (2013) (54)
- Epigenetic therapy for solid tumors: from bench science to clinical trials. (2015) (52)
- Sessile serrated adenomas and classical adenomas: An epigenetic perspective on premalignant neoplastic lesions of the gastrointestinal tract (2011) (51)
- Surgical intensive care unit clinician estimates of the adequacy of communication regarding patient prognosis (2010) (50)
- Promoter Methylation of CDO1 Identifies Clear-Cell Renal Cell Cancer Patients with Poor Survival Outcome (2015) (50)
- Young Patients Undergoing Resection of Pancreatic Cancer Fare Better than their Older Counterparts (2012) (49)
- Understanding the Barriers to Reporting Sexual Harassment in Surgical Training. (2020) (47)
- A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer Patients (2016) (46)
- CpG Island Methylator Phenotype–Positive Tumors in the Absence of MLH1 Methylation Constitute a Distinct Subset of Duodenal Adenocarcinomas and Are Associated with Poor Prognosis (2012) (45)
- Trends and Risk Factors for Transfusion in Hepatopancreatobiliary Surgery (2014) (45)
- Sarcomas in the United States: Recent trends and a call for improved staging (2019) (45)
- The Chicago Consensus on Peritoneal Surface Malignancies: Management of Appendiceal Neoplasms (2020) (44)
- Methylation of TFPI 2 in Stool DNA : A Potential Novel Biomarker for the Detection of Colorectal Cancer (2009) (42)
- Variations in referral patterns to high-volume centers for pancreatic cancer. (2009) (42)
- Long‐term outcomes in treatment of retroperitoneal sarcomas: A 15 year single‐institution evaluation of prognostic features (2016) (42)
- Teaching hospital status and operative mortality in the United States: tipping point in the volume-outcome relationship following colon resections? (2010) (41)
- Extraction and processing of circulating DNA from large sample volumes using methylation on beads for the detection of rare epigenetic events. (2013) (41)
- The Roles of DNA Methylation in the Stages of Cancer. (2017) (40)
- The role of radiation in retroperitoneal sarcomas: a surgical perspective (2007) (40)
- Tracking early readmission after pancreatectomy to index and nonindex institutions: a more accurate assessment of readmission. (2015) (39)
- Role of a Multidisciplinary Clinic in the Management of Patients with Pancreatic Cysts: A Single-Center Cohort Study (2014) (38)
- Assessing the experience in complex hepatopancreatobiliary surgery among graduating chief residents: is the operative experience enough? (2014) (37)
- Management of retroperitoneal sarcomas. (2008) (36)
- A Phase I Trial of a Guadecitabine (SGI-110) and Irinotecan in Metastatic Colorectal Cancer Patients Previously Exposed to Irinotecan (2018) (34)
- AGA Guidelines for the Management of Pancreatic Cysts. (2015) (34)
- Gastric and small intestine gastrointestinal stromal tumors: Do outcomes differ? (2017) (34)
- A novel approach for selecting combination clinical markers of pathology applied to a large retrospective cohort of surgically resected pancreatic cysts (2017) (34)
- Disparities in Colon Cancer Presentation and In-Hospital Mortality in Maryland: A Ten-Year Review (2007) (32)
- Epigenetic silencing of neurofilament genes promotes an aggressive phenotype in breast cancer (2015) (32)
- Management of extremity soft tissue sarcomas. (2008) (32)
- Association of Treatment Inequity and Ancestry With Pancreatic Ductal Adenocarcinoma Survival. (2019) (32)
- Automated diagnosis of colon cancer using hyperspectral sensing (2018) (30)
- Methylation-induced silencing of ASC/TMS1, a pro-apoptotic gene, is a late-stage event in colorectal cancer (2007) (29)
- DNA methylation biomarkers of stool and blood for early detection of colon cancer. (2013) (29)
- Epithelioid sarcoma: one institution's experience with a rare sarcoma. (2012) (28)
- Spectrin Repeat Containing Nuclear Envelope 1 and Forkhead Box Protein E1 Are Promising Markers for the Detection of Colorectal Cancer in Blood (2014) (28)
- The Chicago Consensus on Peritoneal Surface Malignancies: Management of Colorectal Metastases (2020) (28)
- Epigenetic therapy and chemosensitization in solid malignancy. (2017) (28)
- Analysis of Survival Among Adults With Early-Onset Colorectal Cancer in the National Cancer Database (2021) (27)
- Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells (2017) (27)
- Predictors of improved survival for patients with retroperitoneal sarcoma. (2016) (26)
- The Chicago Consensus on Peritoneal Surface Malignancies: Management of Gastric Metastases (2020) (25)
- IGFBP-3 Gene Methylation in Primary Tumor Predicts Recurrence of Stage II Colorectal Cancers (2016) (24)
- A Contemporary Evaluation of the Cause of Death and Long-Term Quality of Life After Total Pancreatectomy (2016) (24)
- Survival Following Lung Metastasectomy in Soft Tissue Sarcomas (2015) (23)
- Low Frequency of Lymph Node Metastases in Patients in the United States With Early-stage Gastric Cancers That Fulfill Japanese Endoscopic Resection Criteria. (2019) (23)
- Circulating Epithelial Cells in Intraductal Papillary Mucinous Neoplasms and Cystic Pancreatic Lesions (2017) (23)
- The Chicago Consensus Guidelines for peritoneal surface malignancies: Introduction (2020) (23)
- Immunotherapy Treatment for Triple Negative Breast Cancer (2021) (23)
- CHFR silencing or microsatellite instability is associated with increased antitumor activity of docetaxel or gemcitabine in colorectal cancer (2014) (22)
- Epigenetically altered miR-1247 functions as a tumor suppressor in pancreatic cancer (2017) (22)
- Extraskeletal versus Skeletal Ewing Sarcoma in the adult population: Controversies in care. (2018) (22)
- The Chicago Consensus on Peritoneal Surface Malignancies: Standards (2020) (21)
- The Emerging Roles of ATP-Dependent Chromatin Remodeling Complexes in Pancreatic Cancer (2019) (21)
- The Chicago Consensus on peritoneal surface malignancies: Palliative care considerations (2020) (21)
- Postoperative Morbidity After Resection of Recurrent Retroperitoneal Sarcoma: A Report from the Transatlantic Australasian RPS Working Group (TARPSWG) (2021) (21)
- The Chicago Consensus on peritoneal surface malignancies: Management of appendiceal neoplasms (2020) (20)
- Long‐term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancer (2017) (20)
- The Chicago Consensus on Peritoneal Surface Malignancies: Management of Desmoplastic Small Round Cell Tumor, Breast, and Gastrointestinal Stromal Tumors (2020) (19)
- Early detection of pancreatic cancer. (2015) (19)
- Clinicopathologic Presentation and Natural History of Anorectal Melanoma: A Case Series of 18 Patients. (2014) (18)
- The Chicago Consensus on Peritoneal Surface Malignancies: Management of Peritoneal Mesothelioma (2020) (18)
- The promise of methylation on beads for cancer detection and treatment (2014) (17)
- Liver transplant patients have a risk of progression similar to that of sporadic patients with branch duct intraductal papillary mucinous neoplasms (2014) (17)
- Resection of retroperitoneal sarcoma en‐bloc with inferior vena cava: 20 year outcomes of a single institution (2018) (17)
- Patterns of recurrence and survival probability after second recurrence of retroperitoneal sarcoma: A study from TARPSWG (2020) (17)
- The Chicago Consensus on peritoneal surface malignancies: Management of gastric metastases (2020) (16)
- The Chicago Consensus on Peritoneal Surface Malignancies: Management of Ovarian Neoplasms (2020) (16)
- The independent effect of cancer on outcomes: a potential limitation of surgical risk prediction. (2017) (16)
- Disparity in limb-salvage surgery among sarcoma patients. (2010) (15)
- Race-based differences in length of stay among patients undergoing pancreatoduodenectomy. (2014) (15)
- Neoantigen-based EpiGVAX vaccine initiates antitumor immunity in colorectal cancer. (2020) (15)
- The Chicago Consensus on peritoneal surface malignancies: Management of ovarian neoplasms (2020) (15)
- A phase 1 trial of the oral DNA methyltransferase inhibitor CC‐486 and the histone deacetylase inhibitor romidepsin in advanced solid tumors (2019) (14)
- Treatment with epigenetic agents profoundly inhibits tumor growth in leiomyosarcoma (2018) (14)
- The role of oncogenes in gastrointestinal cancer. (2010) (14)
- Asian race/ethnicity as a risk factor for bile duct injury during cholecystectomy. (2010) (14)
- Tumors with unmethylated MLH1 and the CpG island methylator phenotype are associated with a poor prognosis in stage II colorectal cancer patients (2016) (13)
- A pressure cooking-based DNA extraction from archival formalin-fixed, paraffin-embedded tissue. (2012) (12)
- Pandemic Recovery Using a COVID-Minimal Cancer Surgery Pathway (2020) (12)
- Genomics of Peritoneal Malignancies. (2018) (12)
- Multimodal Therapy in the Treatment of Prostate Sarcoma: The Johns Hopkins Experience. (2015) (12)
- KRAS G>A mutation favors poor tumor differentiation but may not be associated with prognosis in patients with curatively resected duodenal adenocarcinoma (2013) (12)
- The Chicago Consensus on Peritoneal Surface Malignancies: Management of Neuroendocrine Tumors (2020) (11)
- Abstract 4666: A phase 2 study investigating the safety, efficacy and surrogate biomarkers of response of 5-azacitidine (5-AZA) andentinostat (MS-275) in patients with triple-negative advanced breast cancer. (2013) (11)
- Trends in Outcomes After Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy. (2019) (11)
- Results of COVID-minimal Surgical Pathway During Surge-phase of COVID-19 Pandemic (2020) (11)
- Minimally Invasive Versus Open Primary Resection for Retroperitoneal Soft Tissue Sarcoma: A Propensity-Matched Study From the National Cancer Database (2018) (11)
- MAPT promoter CpG island hypermethylation is associated with poor prognosis in patients with stage II colorectal cancer (2019) (10)
- Operative Mortality Prediction for Primary Rectal Cancer: Age Matters. (2019) (10)
- Analysis of Differentiation Changes and Outcomes at Time of First Recurrence of Retroperitoneal Liposarcoma by Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) (2021) (10)
- Comparing the long‐term outcomes among patients with stomach and small intestine gastrointestinal stromal tumors: An analysis of the National Cancer Database (2018) (10)
- High-dose-rate intraoperative radiation therapy: the nuts and bolts of starting a program (2014) (9)
- CpG island methylator phenotype and its association with malignancy in sporadic duodenal adenomas (2014) (9)
- The Chicago Consensus on peritoneal surface malignancies: Management of peritoneal mesothelioma (2020) (9)
- Early hospital readmission for gastrointestinal-related complications predicts long-term mortality after pancreatectomy. (2015) (9)
- The Chicago Consensus on peritoneal surface malignancies: Management of colorectal metastases (2020) (9)
- Postoperative Onset and Detection of SARS-CoV-2 in Surgically Resected Specimens From Gastrointestinal Cancer Patients With Pre/Asymptomatic COVID-19 (2020) (9)
- High expression of epidermal growth factor receptor might predict poor survival in patients with colon cancer: a meta-analysis. (2013) (8)
- Morbidity and Outcomes After Distal Pancreatectomy for Primary Retroperitoneal Sarcoma: An Analysis by the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group (2021) (8)
- A novel epigenetic modulating agent sensitizes pancreatic cells to a chemotherapy agent (2018) (8)
- Neoadjuvant chemoradiation followed by interstitial prostate brachytherapy for synchronous prostate and rectal cancer. (2012) (8)
- Methylation-based Cell-free DNA Signature for Early Detection of Pancreatic Cancer (2021) (8)
- OT3-01-06: A Phase 2 Study Investigating the Safety, Efficacy and Surrogate Biomarkers of Response of 5-Azacitidine (5-AZA) and Entinostat (MS-275) in Patients with Advanced Breast Cancer. (2011) (7)
- A feasibility study of combined epigenetic and vaccine therapy in advanced colorectal cancer with pharmacodynamic endpoint (2021) (7)
- Time to Chemotherapy After Abdominoperineal Resection: Comparison Between Primary Closure and Perineal Flap Reconstruction (2015) (7)
- Methylation of MGMT Is Associated with Poor Prognosis in Patients with Stage III Duodenal Adenocarcinoma (2016) (7)
- Late-Stage Pancreatic Cancer Detected During High-Risk Individual Surveillance: A Systematic Review and Meta-Analysis. (2021) (7)
- Next-generation Sequencing in the Management of Gastric and Esophageal Cancers. (2019) (7)
- Epigenetic signatures differentiate uterine and soft tissue leiomyosarcoma (2021) (6)
- Differential expression of hENT1 and hENT2 in colon cancer cell lines. (2017) (6)
- Intraabdominal tissue expanders to prevent radiation enteritis: preliminary report. (2010) (6)
- Evaluation of Racial Disparities in Quality of Care for Patients With Gastrointestinal Tract Cancer Treated With Surgery (2022) (5)
- Inpatient survival after gastrectomy for gastric cancer in the 21st century. (2014) (5)
- Zerumbone, a Sesquiterpene from Southeast Asian Edible Ginger Sensitizes Colorectal Cancer Cells to Radiation Therapy (2010) (5)
- Lessons Learned from a Palliative Care-Related CommunicationIntervention in an Adult Surgical Intensive Care Unit (2015) (5)
- Postoperative complications following intraoperative radiotherapy in abdominopelvic malignancy: A single institution analysis of 113 consecutive patients (2017) (5)
- The Chicago Consensus on peritoneal surface malignancies: Management of desmoplastic small round cell tumor, breast, and gastrointestinal stromal tumors (2020) (4)
- Improving Sensitivity to Irinotecan Using 5-Azacytidine in Colon Cancer Cell Lines (2013) (4)
- Abstract 995: Transient low doses of DNA demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells (2012) (4)
- Personalized Approaches to Gastrointestinal Cancers: Importance of Integrating Genomic Information to Guide Therapy. (2015) (4)
- Epigenetic priming prior to pembrolizumab in mismatch repair-proficient advanced colorectal cancer. (2019) (4)
- A Comparison of Open and Minimally Invasive Surgery for Hepatic & Pancreatic Resections Using the Nationwide Inpatient Sample (NIS) (2014) (4)
- The Chicago Consensus on peritoneal surface malignancies: Standards (2020) (4)
- Locally advanced primary recto-sigmoid cancers: Improved survival with multivisceral resection. (2017) (4)
- Translational research in surgical disease. (2010) (4)
- Can echogenic appearance of neuroendocrine liver metastases on intraoperative ultrasonography predict tumor biology and prognosis? (2018) (4)
- Targeting the epigenome of pancreatic cancer for therapy: challenges and opportunities (2019) (4)
- Epigenetics of gastrointestinal diseases: notes from a workshop (2018) (4)
- Image of the month. Incarcerated sigmoid volvulus in a right inguinal hernia. (2007) (4)
- Comparison of Male and Female Surgeons' Experiences With Gender Across 5 Qualitative/Quantitative Domains. (2022) (3)
- Subclassification of microsatellite-unstable tumors in colorectal cancer (2007) (3)
- Adaptive immune resistance in gastro-esophageal cancer: Correlating tumoral/stromal PDL1 expression with CD8+ cell count. (2015) (3)
- BENEFIT OF EXTENDED SURVEILLANCE OF LOW-RISK PANCREATIC CYSTS AFTER FIVE-YEAR STABILITY: A SYSTEMATIC REVIEW AND META-ANALYSIS. (2022) (3)
- Management of Low-Grade Appendiceal Mucinous Neoplasms (LAMN): An International Survey of Surgeons Performing CRS and HIPEC (2021) (3)
- DNA methylation changes in extracellular remodeling pathway genes during the transformation of human mesenchymal stem cells (2016) (3)
- Retroperitoneal masses with associated human chorionic gonadotropin production: Report of two cases. (2008) (3)
- Abstract 94: Epigenetic silencing of CDO1 sustains viability of breast cancer cells via the reduction of cellular ROS (2012) (3)
- The Chicago Consensus on Peritoneal Surface Malignancies: Palliative Care Considerations (2020) (3)
- Phase 2 study investigating the safety, efficacy, and surrogate biomarkers of response to 5-azacitidine (5-AZA) and entinostat in advanced breast cancer. (2014) (3)
- Soft tissue sarcomas. Preface. (2008) (3)
- Genomics of peritoneal surface malignancies (2017) (2)
- Asparagine Metabolism in Tumors Is Linked to Poor Survival in Females with Colorectal Cancer: A Cohort Study (2021) (2)
- The Chicago Consensus Guidelines for Peritoneal Surface Malignancies: Introduction (2020) (2)
- Correction: Inhibiting DNA methylation activates cancer testis antigens and expression of the antigen processing and presentation machinery in colon and ovarian cancer cells (2020) (2)
- 80: What constitutes a “high volume” hospital for pancreatic resection? (2007) (2)
- 12LBA A Plasma-based colorectal cancer (CRC) screening assay using DNA methylation markers - first results of multicenter studies (2009) (2)
- A phase 2 trial of gemcitabine and docetaxel in patients with metastatic colorectal adenocarcinoma with methylated checkpoint with forkhead and ring finger domain promoter and/or microsatellite instability phenotype (2021) (2)
- High dose-rate Intra-Operative Radiation Therapy During High Risk Genitourinary Surgery: Initial Observations and a Proposal for its Study in Bladder Cancer (2017) (2)
- A phase II study of combination epigenetic therapy in metastatic colorectal cancer (mCRC): A phase II consortium (P2C)/Stand Up 2 Cancer (SU2C) study. (2013) (2)
- Abstract CT017: A phase I study of guadecitabine (GUA) combined with irinotecan (IRI) in previously treated metastatic colorectal cancer (mCRC) patients (2016) (2)
- Lessons from the COVID-19 Pandemic: The Case for Virtual Residency Interviews (2021) (2)
- Implementing survivorship care planning in two contrasting health systems: lessons learned from a randomized controlled trial (2021) (2)
- The Chicago Consensus on peritoneal surface malignancies: Management of neuroendocrine tumors (2020) (1)
- Anti-Tumour Treatment Epigenetic therapy and chemosensitization in solid malignancy (2017) (1)
- A phase I trial of oral 5-azacitidine in combination with romidepsin in advanced solid tumors with an expansion cohort in virally mediated cancers and liposarcoma. (2015) (1)
- Blood-based screening for methylation changes in colorectal cancer patients using novel nanotechnologies. (2013) (1)
- Differential expression of hENT 1 and hENT 2 in colon cancer cell lines (2017) (1)
- Hospital Volume and Patient Outcomes in Hepato-Pancreato-Biliary Surgery: is Assessing Differences in Mortality Enough? (2014) (1)
- Abstract B43: Early detection biomarker of pancreatic cancer using a nanoparticle-based methylation assay (2011) (1)
- A phase I study of investigational agent SGI-110 combined with irinotecan in previously treated metastatic colorectal cancer patients. (2015) (1)
- Prognosis CpG Island Methylator Phenotype – Positive Tumors in the Absence of MLH 1 Methylation Constitute a Distinct Subset of Duodenal Adenocarcinomas and Are Associated with Poor Prognosis (2012) (1)
- Variations in recommended surveillance in colorectal cancer survivorship care plans. (2020) (1)
- 17 – Surveillance and Follow-up (2011) (1)
- Correction: Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells (2020) (1)
- Association of recurrence patterns following resection of pancreatic adenocarcinoma with overall survival. (2014) (1)
- Epigenetic priming prior to pembrolizumab in microsatellite-stable (MSS) advanced colorectal cancer. (2016) (0)
- Abstract A35: Treatment with demethylating drugs inhibits tumor growth in leiomyosarcoma cell lines and xenograft models (2018) (0)
- Analysis of Cone BeamCT Shifts in Image Guided Radiation Therapy for Abdominopelvic Soft-tissue Sarcomas (2012) (0)
- Asian race as a risk factor for bile duct injury during cholecystectomy (2009) (0)
- 9 – Stool and Blood Sampling for Early Detection of Colorectal Cancer (2011) (0)
- How Male and Female Surgeons’ Experiences with Gender in Surgery Compare: National Concurrent Mixed-Methods Survey of Fellows of the American College of Surgeons (2022) (0)
- Assessing the Experience in Complex Hepatopancreatobiliary Surgery Among Graduating Chief Residents: Is the Operative Caseload Enough? (2014) (0)
- Chapter 11 – Prognostic Epigenetics (2016) (0)
- Four Hundred Consecutive Total Gastrectomies for Gastric Cancer—Invited Critique (2008) (0)
- M1629 Preoperative Biopsy Findings Correlate Poorly With Postoperative Findings in IBD-Associated Neoplasia (2010) (0)
- Portal/superior mesenteric vein resection during pancreatic surgery: evolution of technique and lessons learned (2014) (0)
- Referee Acknowledgement for 2014 (2015) (0)
- Discovery of early detection markers of pancreatic cancer and clinical application in blood-based screening (2013) (0)
- Bile acid distributions, sex-specificity, and prognosis in colorectal cancer (2022) (0)
- Epithelial Sarcomas: Experience From a Single Institution (2012) (0)
- Firm flank mass decreasing in size after pregnancy. (2014) (0)
- S0101 Clinical and Demographic Predictors of Rapidly Progressive Disease in Patients Undergoing Surgery for Pancreatic Ductal Adenocarcinoma: Risk Profiling From the National Cancer Database (2020) (0)
- Passive hyperspectral sensing to identify colorectal cancer in intraoperative colon specimens. (2016) (0)
- O1-10-3Associations of IGFBP3 SNPs, methylation and recurrence risk in patients with stage II colorectal cancer (2016) (0)
- Introduction to the Special Edition of Annals of Surgery: The Johns Hopkins Festschrift. (2018) (0)
- DNA methylation changes in extracellular remodeling pathway genes during the transformation of human mesenchymal stem cells (2016) (0)
- Correction (2005) (0)
- Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood (2019) (0)
- M1592 Is There Any Role for Resection for Stage IV Gastric Cancers (2009) (0)
- Correction: A novel epigenetic modulating agent sensitizes pancreatic cells to a chemotherapy agent (2020) (0)
- Methylation-induced silencing of TFPI-2 is an early-stage event in colorectal cancer (2008) (0)
- Use of distinct molecular signatures of appendiceal cancer subtypes to assess biomarker development. (2023) (0)
- Utility of promoter hypermethylation in malignant risk stratification of intraductal papillary mucinous neoplasms (2023) (0)
- High-Dose Rate Brachytherapy Increases Disease-Free Survival for Retroperitoneal Sarcomas (2018) (0)
- Gender Disparity in National Institutes of Health Funding Among Surgeon-Scientists From 1995 to 2020 (2023) (0)
- Innovative Two-Stage Process to Standardize Best Practices to Improve Patient Mortality (2016) (0)
- Abstract 898: Survival for patients with early-onset colorectal cancer - An overall survival analysis from the National Cancer Database, 2004-2015 (2021) (0)
- Tu1185: DOES CURRENT EVIDENCE SUPPORT CYST GROWTH RATE AS A WORRISOME FEATURE? A SYSTEMATIC REVIEW AND META-ANALYSIS (2022) (0)
- 1147: DISPARITIES IN TIME TO TREATMENT INITIATION IN COLORECTAL CANCER IN THE US FROM 2004-2018: ANALYSIS OF THE NATIONAL CANCER DATABASE (2022) (0)
- Methylation of CDO 1 , HOXA 9 , and TAC 1 for the Diagnosis of Lung Cancer (2014) (0)
- Quick shots: Wednesday 2/4 3:30 pmClinical trials and outcomes 6: Disparities and outcomesQS47. Age and Racial Disparities in Access to High Volume Centers for Colorectal Cancer. Who Makes the Cut? (2009) (0)
- MP23-12 INTRAOPERATIVE RADIATION THERAPY DURING GENITOURINARY SURGERY: THE IMPORTANCE OF SPECIMEN MARGIN STATUS IN IMPROVING SURVIVAL (2016) (0)
- Prognostic factors after pancreaticoduodenectomy for duodenal adenocarcinoma: Results from a dual center analysis. (2014) (0)
- Correction: ASO Visual Abstract: An Analysis of Differentiation Changes and Outcomes at the First Recurrence of Retroperitoneal Liposarcoma by the Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) (2022) (0)
- Overcoming immune system evasion by personalized immunotherapy. (2014) (0)
- Abstract LB-88: Transient exposure to low-dose decitabine and azacytidine reprograms cancer cells to produce a prolonged antitumor response (2010) (0)
- W1755 Exploring Combination Epigenetic Therapy for the Treatment of Colorectal Cancer (2009) (0)
- 140 Portal/Superior Mesenteric Vein Resections During Pancreaticoduodenectomy: Evolution of Technique and Lessons Learned (2013) (0)
- Mo1131: HIGHLY SPECIFIC PROMOTER METHYLATION MARKERS FOR MALIGANT STRATIFICATION OF INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS (2022) (0)
- Early Detection of Cancers in the Era of Precision Oncology. (2023) (0)
- Mo1163 A Multicenter Study Evaluating Risk Factors of Lymph Node Metastasis in Early Gastric Cancer in the United States (2017) (0)
- Sa298 IS IT SAFE TO STOP SURVEILLANCE OF PANCREATIC CYSTS AFTER 5 YEARS OF STABILITY?: A SYSTEMATIC REVIEW AND META-ANALYSIS OF CURRENT EVIDENCE. (2021) (0)
- Abstract PO-155: Racial heterogeneity in the molecular landscape of pancreatic adenocarcinoma: A call for action (2022) (0)
- Correction to: Analysis of Differentiation Changes and Outcomes at Time of First Recurrence of Retroperitoneal Liposarcoma by Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) (2022) (0)
- Biomarkers to tailor chemoradiation therapies. (2012) (0)
- Hyperspectral imaging for passive detection of colorectal cancers (2017) (0)
- Compositions and methods to detect a neoplasm (2011) (0)
- Sa302 IS MULTIFOCALITY IN INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS A RISK FACTOR FOR PANCREATIC MALIGNANCY?: A SYSTEMATIC REVIEW AND META-ANALYSIS (2021) (0)
- A randomized phase II trial of epigenetic therapy following adjuvant treatment in patients with resected pancreatic cancer and high risk for recurrence. (2015) (0)
- A phase II study of Guadecitabine (G) with Irinotecan (IRI) vs regorafenib or TAS-102 in metastatic colorectal cancer (mCRC) patients (pts) (2020) (0)
- Imaging , Diagnosis , Prognosis CpG Island Methylator Phenotype – Positive Tumors in the Absence of MLH 1 Methylation Constitute a Distinct Subset of Duodenal Adenocarcinomas and Are Associated with Poor Prognosis (2012) (0)
- Use of Gene Expression Profiles in Cells of Peripheral Blood to Identify New Molecular Markers of Acute Pancreatitis—Invited Critique (2008) (0)
- 597 Molecular Markers Help Define Cyst Type in the Pancreas: An International, Multicenter Study of Over 300 Cysts (2016) (0)
- Epigenetic Upregulation of Beta-2 Microglobulin in Microsatellite Stable Colon Cancer Cell Lines (2013) (0)
- Early outcomes after elective colorectal surgery in end stage renal disease (ESRD) vs non-ESRD Patients (2015) (0)
- Abstract C54: GATA6 level is a prognostic biomarker for pancreatic cancer in African American patients (2019) (0)
- A randomized, phase II trial of oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrence (2022) (0)
- Quantifying the Surgical Residency Match in the Zoom Era: Applicant Volume, Match Rates, and Where We Go Next (2022) (0)
- 5 – Behavior and Dietary Modification in the Prevention of Colon Cancer (2011) (0)
- Cost and outcomes analysis of robotic, laparoscopic, and open colon resection: a national study (2013) (0)
- MC13-0076 CHFR silencing and microsatellite instability as predictors of sensitivity to docetaxel and gemcitabine in colorectal cancer (2013) (0)
- Black and Hispanic Pancreaticoduodenectomy Patients Are Treated by Lower Volume Providers and Have Longer Hospital Stays Compared with White Patients (2014) (0)
- Passive Hyperspectral Sensing Reliably Identifies Colorectal Cancer in Intraoperative Colon Specimens (2016) (0)
- A feasibility study of combined epigenetic and vaccine therapy in advanced colorectal cancer with pharmacodynamic endpoint (2021) (0)
- Colorectal cancer stem cells--hype or real?: comment on "Combined CD133+/CD44+ expression as a prognostic indicator of disease-free survival in patients with colorectal cancer". (2012) (0)
- Abstract 2618: DNMT1 as a marker of differential sensitivities to epigenetic therapy of a Kras mutant and Kras wild type human non small cell lung cancer cell line (2011) (0)
- Cystic lesions of the pancreas: Why we get it wrong (2016) (0)
- Comprar Early Diagnosis of Cancer Series: Colon Cancer | Susan Gearhart | 9781416046868 | Saunders (2008) (0)
- QS277. The Effect of Teaching Hospital Status on Operative Mortality and Outcomes Following Colorectal Cancer Resection (2009) (0)
- Correction to: Postoperative Morbidity After Resection of Recurrent Retroperitoneal Sarcoma: A Report from the Transatlantic Australasian RPS Working Group (TARPSWG) (2022) (0)
- The CpG island methylator phenotype (CIMP): What’s in a name? (2013) (0)
- Abstract B23: Bioadhesive nanoparticles as a delivery vehicle in pancreatic cancer epithelial cells and pancreatic fibroblasts (2019) (0)
- 557 Epigenetic Regulation of WNT Signaling Pathway Genes in Inflammatory Bowel Disease (IBD) Neoplasia (2008) (0)
- An asterisk indicates reviewers who have evaluated three or more manuscripts in 2012. (2013) (0)
- Standard Fractionation External Beam Radiation Therapy With and Without Intraoperative Radiation Therapy for Patients With Locally Recurrent Rectal Cancer (2015) (0)
- Abstract #LB-276: Intersection of genomic and epigenomic gene approaches identifies global disruption of the ECM pathway in colorectal cancer (2009) (0)
- Epidemiology and treatment outcome among patients with desmoplastic small round cell tumors (2015) (0)
- Abstract PO-015: Hypermethylated genes in leiomyosarcoma can be targeted through guadecitabine treatment (2020) (0)
- 42. Utilization of Genomic Approaches to Identify the Hypermethylome of Colorectal Cancer - A Strategy for Biomarker Discovery (2008) (0)
- A Bioinformatics Pipeline for Cancer Epigenetics (2010) (0)
- 55: Early Methylation of SYNE1 in Colorectal Cancer: Implications for Stool-Based Colorectal Cancer Screening (2009) (0)
- Potential pitfalls associated with using a cut-point of 12 lymph nodes as a quality of care measure for patients with NO adenocarcinoma of the colon (2007) (0)
- The heat of the matter. (2012) (0)
- Comprar Sarcoma, An Issue of Surgical Clinics | Matthew Hueman | 9781416058052 | Saunders (2008) (0)
- EPIGENETIC PRIMING WITH 5‐AZACITIDINE INCREASES SENSITIVITY OF BLADDER CANCER CELLS TO CHEMOTHERAPEUTIC AGENTS: MP65‐20 (2017) (0)
- Syne1 Promoter Hypermethylation as a Predictor of Tumor Aggressiveness in Primary Breast Cancer (2008) (0)
- Use of [18F]-2-Fluoro-2-deoxy-D-glucose Positron Emission Tomography in the Management of Colorectal Cancer (2011) (0)
- Colorectal cancer survivorship care plans: Variations in documentation and posttreatment surveillance recommendations (2021) (0)
- Correction: Morbidity and Outcomes After Distal Pancreatectomy for Primary Retroperitoneal Sarcoma: An Analysis by the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group (2022) (0)
- Epigenetic Therapy Drugs Boost Immune Attraction Properties of Epithelial Cancer Cells (2016) (0)
- ASO Visual Abstract: An Analysis of Differentiation Changes and Outcomes at the First Recurrence of Retroperitoneal Liposarcoma by the Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) (2021) (0)
- Is the debate finally over?: Comment on "Survival Effects of Adjuvant Chemoradiation Following Chemoradiotherapy After Resection for Pancreatic Carcinoma". (2010) (0)
- Lymph Node Evaluation by Tumor Location in Colon Cancer Elderly Patients: A SEER-Medicare Study (2012) (0)
- A study of using epigenetic modulators to enhance response to pembrolizumab (MK-3475) in microsatellite stable advanced colorectal cancer (2023) (0)
- 20 – Genetic Profiling in Colorectal Cancer (2011) (0)
- Inpatient Survival after Gastrectomy for Gastric Cancer in the 21st Century: Are We Making Progress? (2014) (0)
This paper list is powered by the following services:
Other Resources About Nita Ahuja
What Schools Are Affiliated With Nita Ahuja?
Nita Ahuja is affiliated with the following schools:
